Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.100
-0.010 (-0.90%)
At close: Nov 22, 2024, 4:00 PM
1.080
-0.020 (-1.80%)
After-hours: Nov 22, 2024, 5:41 PM EST
Immunic Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 99 | 68 | 62 | 251 | 317 | 98 | |
| Market Cap Growth | 126.73% | 9.04% | -75.28% | -20.70% | 222.80% | - | |
| Enterprise Value | 41 | 9 | -10 | 142 | 185 | 68 | |
| Last Close Price | 1.10 | 1.50 | 1.40 | 9.57 | 15.29 | 9.70 | |
| PB Ratio | 2.40 | 2.34 | 0.55 | 1.98 | 2.00 | 1.68 | |
| P/TBV Ratio | 3.61 | 2.34 | 0.55 | 2.67 | 2.52 | 3.86 | |
| Debt / Equity Ratio | 0.02 | 0.05 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 2.56 | 1.99 | 9.10 | 7.81 | 15.37 | 4.26 | |
| Current Ratio | 2.71 | 2.12 | 9.62 | 9.21 | 15.93 | 4.56 | |
| Return on Equity (ROE) | -216.24% | -131.28% | -100.01% | -65.02% | -40.54% | -100.07% | |
| Return on Assets (ROA) | -90.90% | -68.13% | -40.53% | -30.30% | -26.18% | -58.35% | |
| Return on Capital (ROIC) | -130.20% | -85.24% | -44.44% | -32.31% | -28.00% | -65.81% | |
| Earnings Yield | -97.80% | -138.24% | -193.89% | -37.00% | -13.89% | -35.60% | |
| FCF Yield | -76.96% | -105.09% | -105.08% | -33.16% | -14.61% | -29.14% | |
| Buyback Yield / Dilution | -101.53% | -39.29% | -34.53% | -51.00% | -102.84% | -811.77% | |
| Total Shareholder Return | -101.53% | -39.29% | -34.53% | -51.00% | -102.84% | -811.77% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.